Drug action(s), drug marketing, and clinical medicine : suppression of ventricular arrhythmogenicity with if blockade in human heart failure : emerging clinical evidence for ivabradine treatment benefit beyond heart rate control
Drug action(s), drug marketing, and clinical medicine : suppression of ventricular arrhythmogenicity with if blockade in human heart failure : emerging clinical evidence for ivabradine treatment benefit beyond heart rate control
Drug action(s), drug marketing, and clinical medicine : suppression of ventricular arrhythmogenicity with if blockade in human heart failure : emerging clinical evidence for ivabradine treatment benefit beyond heart rate control
Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa